SHAMINA KHAN: Open Payments
NPI 1316241649 · PEORIA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,553 in 75 payments from 22 companies in 2025. Trend: 2023 $1,834 · 2024 $866 · 2025 $1,553
Food & beverage: $1,553
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 18 | $373 |
| Novo Nordisk Inc | 11 | $270 |
| ABBVIE INC. | 12 | $183 |
| Abbott Laboratories | 6 | $143 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $87 |
| Cleerly, Inc. | 1 | $58 |
| Inspire Medical Systems, Inc. | 2 | $58 |
| Aimmune Therapeutics, Inc. | 2 | $52 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
| Eisai Inc. | 2 | $43 |
Products named: REPATHA, VRAYLAR, OTEZLA, Kerendia, Ozempic, Cleerly Ischemia, INSPIRE, ZENPEP.
Industry payments across AZ — which companies pay providers there.
